Lenox Wealth Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-375
| Closed | -$37K | – | 856 |
|
|
2019
Q3 | $37K | Buy |
+375
| New | +$35.6K | 0.01% | 185 |
|
|
2018
Q3 | – | Sell |
-5
| Closed | – | – | 557 |
|
|
2018
Q2 | $0 | Sell |
5
-56
| -92% | -$4.65K | ﹤0.01% | 686 |
|
|
2018
Q1 | $5K | Sell |
61
-193
| -76% | -$18.5K | ﹤0.01% | 425 |
|
|
2017
Q4 | $27K | Buy |
254
+248
| +4,133% | +$28K | 0.01% | 130 |
|
|
2017
Q3 | $1K | Buy |
+6
| New | +$817 | ﹤0.01% | 228 |
|
|
2016
Q4 | – | Sell |
-25
| Closed | -$3K | – | 209 |
|
|
2016
Q3 | $3K | Buy |
+25
| New | +$2.71K | ﹤0.01% | 200 |
|
|
2016
Q2 | – | Sell |
-90
| Closed | -$9K | – | 280 |
|
|
2016
Q1 | $9K | Sell |
90
-60
| -40% | -$6.18K | ﹤0.01% | 172 |
|
|
2015
Q4 | $18K | Buy |
150
+104
| +226% | +$12K | 0.01% | 150 |
|
|
2015
Q3 | $5K | Hold |
46
| – | – | ﹤0.01% | 265 |
|
|
2015
Q2 | $5K | Hold |
46
| – | – | ﹤0.01% | 222 |
|
|
2015
Q1 | $5K | Hold |
46
| – | – | ﹤0.01% | 244 |
|
|
2014
Q4 | $5K | Hold |
46
| – | – | ﹤0.01% | 249 |
|
|
2014
Q3 | $4K | Hold |
46
| – | – | ﹤0.01% | 253 |
|
|
2014
Q2 | $4K | Sell |
46
-154
| -77% | -$11.7K | ﹤0.01% | 174 |
|
|
2014
Q1 | $15K | Buy |
+200
| New | +$15.8K | 0.01% | 115 |
|
|
2013
Q4 | – | Sell |
-200
| Closed | -$15K | – | 433 |
|
|
2013
Q3 | $15K | Hold |
200
| – | – | 0.01% | 79 |
|
|
2013
Q2 | $12K | Buy |
+200
| New | +$12K | 0.01% | 107 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Lenox Wealth Advisors's CELG Position: Q4 2019 in Review
Lenox Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 375 shares — an estimated $37K sold.
Lenox Wealth Advisors first reported a position in CELG in Q2 2013 and held it in 17 quarters. The position peaked at $37K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Lenox Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Lenox Wealth Advisors sold 375 Celgene Corp shares in Q4 2019, an estimated $37K.
- Lenox Wealth Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 17 quarters.
- Lenox Wealth Advisors's Celgene Corp position peaked at $37K in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Lenox Wealth Advisors's 13F filing for Q4 2019, filed 6 Jan 2020.